4396 related articles for article (PubMed ID: 24336571)
1. Genome-scale CRISPR-Cas9 knockout screening in human cells.
Shalem O; Sanjana NE; Hartenian E; Shi X; Scott DA; Mikkelson T; Heckl D; Ebert BL; Root DE; Doench JG; Zhang F
Science; 2014 Jan; 343(6166):84-87. PubMed ID: 24336571
[TBL] [Abstract][Full Text] [Related]
2. High-resolution interrogation of functional elements in the noncoding genome.
Sanjana NE; Wright J; Zheng K; Shalem O; Fontanillas P; Joung J; Cheng C; Regev A; Zhang F
Science; 2016 Sep; 353(6307):1545-1549. PubMed ID: 27708104
[TBL] [Abstract][Full Text] [Related]
3. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex.
Konermann S; Brigham MD; Trevino AE; Joung J; Abudayyeh OO; Barcena C; Hsu PD; Habib N; Gootenberg JS; Nishimasu H; Nureki O; Zhang F
Nature; 2015 Jan; 517(7536):583-8. PubMed ID: 25494202
[TBL] [Abstract][Full Text] [Related]
4. Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screen.
Goh CJH; Wong JH; El Farran C; Tan BX; Coffill CR; Loh YH; Lane D; Arumugam P
G3 (Bethesda); 2021 Feb; 11(2):. PubMed ID: 33604667
[TBL] [Abstract][Full Text] [Related]
5. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood.
Joung J; Engreitz JM; Konermann S; Abudayyeh OO; Verdine VK; Aguet F; Gootenberg JS; Sanjana NE; Wright JB; Fulco CP; Tseng YY; Yoon CH; Boehm JS; Lander ES; Zhang F
Nature; 2017 Aug; 548(7667):343-346. PubMed ID: 28792927
[TBL] [Abstract][Full Text] [Related]
6. Genetic screens in human cells using the CRISPR-Cas9 system.
Wang T; Wei JJ; Sabatini DM; Lander ES
Science; 2014 Jan; 343(6166):80-4. PubMed ID: 24336569
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
Peng J; Zhou Y; Zhu S; Wei W
FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance to RAF inhibitors in melanoma.
Aplin AE; Kaplan FM; Shao Y
J Invest Dermatol; 2011 Sep; 131(9):1817-20. PubMed ID: 21593776
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma.
Patil A; Manzano M; Gottwein E
Blood Adv; 2019 Jul; 3(14):2105-2117. PubMed ID: 31300418
[TBL] [Abstract][Full Text] [Related]
10. Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries.
Rocha CRR; Reily Rocha A; Molina Silva M; Rodrigues Gomes L; Teatin Latancia M; Andrade Tomaz M; de Souza I; Karolynne Seregni Monteiro L; Menck CFM
Cells; 2020 Dec; 9(12):. PubMed ID: 33271924
[TBL] [Abstract][Full Text] [Related]
11. Resistance to RAF inhibitors revisited.
Hartsough E; Shao Y; Aplin AE
J Invest Dermatol; 2014 Feb; 134(2):319-325. PubMed ID: 24108405
[TBL] [Abstract][Full Text] [Related]
12. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
[TBL] [Abstract][Full Text] [Related]
13. Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.
Kiessling MK; Schuierer S; Stertz S; Beibel M; Bergling S; Knehr J; Carbone W; de Vallière C; Tchinda J; Bouwmeester T; Seuwen K; Rogler G; Roma G
BMC Genomics; 2016 Sep; 17(1):723. PubMed ID: 27613601
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively.
Zhou X; Li R; Jing R; Zuo B; Zheng Q
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1509-1521. PubMed ID: 32266537
[TBL] [Abstract][Full Text] [Related]
15. Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells.
Mologni L; Costanza M; Sharma GG; Viltadi M; Massimino L; Citterio S; Purgante S; Raman H; Pirola A; Zucchetti M; Piazza R; Gambacorti-Passerini C
Neoplasia; 2018 May; 20(5):467-477. PubMed ID: 29605720
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection.
Kim HS; Lee K; Bae S; Park J; Lee CK; Kim M; Kim E; Kim M; Kim S; Kim C; Kim JS
J Biol Chem; 2017 Jun; 292(25):10664-10671. PubMed ID: 28446605
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.
Thomsen EA; Mikkelsen JG
Methods Mol Biol; 2019; 1961():343-357. PubMed ID: 30912056
[TBL] [Abstract][Full Text] [Related]
19. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.
Van Allen EM; Wagle N; Sucker A; Treacy DJ; Johannessen CM; Goetz EM; Place CS; Taylor-Weiner A; Whittaker S; Kryukov GV; Hodis E; Rosenberg M; McKenna A; Cibulskis K; Farlow D; Zimmer L; Hillen U; Gutzmer R; Goldinger SM; Ugurel S; Gogas HJ; Egberts F; Berking C; Trefzer U; Loquai C; Weide B; Hassel JC; Gabriel SB; Carter SL; Getz G; Garraway LA; Schadendorf D;
Cancer Discov; 2014 Jan; 4(1):94-109. PubMed ID: 24265153
[TBL] [Abstract][Full Text] [Related]
20. Single-step generation of gene knockout-rescue system in pluripotent stem cells by promoter insertion with CRISPR/Cas9.
Matsunaga T; Yamashita JK
Biochem Biophys Res Commun; 2014 Feb; 444(2):158-63. PubMed ID: 24462858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
